Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS2 in Anterior Uveitis
NCT02406209Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- Mar 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reproxalap in anterior uveitis (AU), sponsored by Aldeyra Therapeutics. Started Mar 2015; status: completed.
02
Drugs
reproxalap
03
Conditions
anterior uveitis (AU)
Beyond the preview
Go deeper on NCT02406209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02406209.